Document ID: chunk:federal_register_of_legislation:F2022C01121:front:0:p5
Version: federal_register_of_legislation:F2022C01121
Segment Type: other
Provision Reference: 
Character Range: 11549–14791

agranulocytosis, at the time of the clinical worsening of gingivitis;
            Note: Examples of drugs that cause neutropenia or agranulocytosis include clozapine, sulfasalazine, ticlopidine and thioamides such as methimazole, carbimazole and propylthiouracil.
         (27)      having severe vitamin C deficiency at the time of the clinical worsening of gingivitis;
Note: severe vitamin C deficiency is defined in the Schedule 1 - Dictionary.
         (28)      having stem cell transplant or bone marrow transplant before the clinical worsening of gingivitis;
         (29)      being pregnant at the time of the clinical worsening of gingivitis;
         (30)      using the combined oral contraceptive pill as specified for a continuous period of at least the 4 weeks before the clinical worsening of gingivitis;
Note: combined oral contraceptive pill as specified is defined in the Schedule 1 - Dictionary.
         (31)      having an autoimmune or mucocutaneous disease from the specified list of autoimmune or mucocutaneous diseases at the time of the clinical worsening of gingivitis;
            Note: specified list of autoimmune or mucocutaneous diseases is defined in the Schedule 1 - Dictionary.
         (32)      having diabetes mellitus at the time of the clinical worsening of gingivitis;
         (33)      having infection involving the affected region of the gums at the time of the clinical worsening of gingivitis;
            Note: Examples of infections that may involve the gums include tuberculosis, gonorrhoea, syphilis, chickenpox, candidiasis, histoplasmosis, herpes simplex and hand, foot and mouth disease.
         (34)      for acute necrotising ulcerative gingivitis only:
            (a)          having severe malnutrition at the time of the clinical worsening of acute necrotising ulcerative gingivitis; or
            (b)          having smoked tobacco products:
(i)            in an amount of at least 5 pack-years before the clinical worsening of acute necrotising ulcerative gingivitis; and
(ii)         if smoking has ceased before the clinical worsening of acute necrotising ulcerative gingivitis, then that worsening occurred within 1 month of cessation;
            Note: acute necrotising ulcerative gingivitis and one pack-year are defined in the Schedule 1 - Dictionary.
         (35)      inability to obtain appropriate clinical management for gingivitis.
     10           Relationship to service
(1)          The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
(2)          The factors set out in subsections 9(18) to 9(35) apply only to material contribution to, or aggravation of, gingivitis where the person's gingivitis was suffered or contracted before or during (but did not arise out of) the person's relevant service.
     11           Factors referring to an injury or disease covered by another Statement of Principles
In this Statement of Principles:
(1)          if a factor referred to in section 9 applies in relation to a person; and
(2)          that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(3) of the VEA;